Ask AI
ProCE Banner Activity

Rationale for Targeting NTRK Fusions in Head and Neck Cancers: Slides

Slideset Download
Downloadable slides to review the rationale for treating NTRK fusions in patients with head and neck cancer.

Released: December 21, 2020

Expiration: December 20, 2021

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Bayer Healthcare Pharma

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

Aarti Bhatia, MD, MPH

Assistant Professor
Division of Medical Oncology
Department of Internal Medicine
Yale Cancer Center
New Haven, Connecticut